CTOs on the Move

Geyer Printing Co Inc

www.geyerprinting.com

 
Geyer Printing Co Inc is a Pittsburgh, PA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Mygo Consulting Inc.

Mygo Consulting Inc. is a global SAP professional services firm based in Naperville, Illinois, with offices in Canada, Germany, India, and Mexico. Founded in August 2013, Mygo specializes in digital supply chain transformation and business innovation, positioning itself as a leader in SAP consulting. The company offers a range of services, including digital supply chain transformation, assistance with the SAP S/4HANA transition, and enhancements to enterprise user experience through design thinking. Mygo also operates a Testing Center of Excellence, providing testing services to ensure high-quality SAP implementations. As an SAP Tricentis reseller and implementation partner, Mygo collaborates with leading technology companies, including Zebra Technologies, to deliver effective solutions. Mygo Consulting is dedicated to a customer-first approach and aims to excel in mission-critical SAP implementations. The company values professional excellence and fosters a strong team culture, reflecting its commitment to both its clients and employees.

G M S International Inc

G M S International Inc is a Cresskill, NJ-based company in the Business Services sector.

Absolute Marketing Group Inc

Absolute Marketing Group Inc is a Voorhees, NJ-based company in the Business Services sector.

Orange Leaders

Curriculum, training, and resources for future thinking childrens ministry and youth ministry leaders.

Satellos

Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.